{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:25:40Z","timestamp":1790947540514,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Family Medicine and Community Health, UW School of Medicine and Public Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fentanyl adulteration of illicit drugs is a major driver of opioid-involved overdose in the USA. Fentanyl test strips are increasingly used by people who use drugs to check for fentanyl. However, little is known about factors that influence test strip use in this population.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this mixed-methods study employing semi-structured open-ended interviews (<jats:italic>n<\/jats:italic>\u2009=\u200929) and a structured survey (<jats:italic>n<\/jats:italic>\u2009=\u2009341), we examined characteristics associated with test strip use, characteristics of test strip use, and situational, logistical and psychosocial factors influencing test strip use. Respondents were recruited from a syringe service program in southern Wisconsin. Bivariate tests of association and multivariable logistic regression examined the relationship between respondent characteristics and test strip use. Summary statistics were used to describe how situational, logistical and psychosocial factors impact test strip use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most respondents were male (59.6%), non-Hispanic white (77.4%), young (mean 35.7\u00a0years), reported heroin as their primary drug (70.7%), injection as their primary route (87.9%), and use \u2265\u20093 times daily (78.6%). In multivariable models, site, race and ethnicity, drug of choice, and seeking fentanyl were associated with test strip use. Among test strip users, 36.5% use them most of the time or more and 80.6% get positive results half the time or more. Among individuals reporting heroin, fentanyl, methamphetamine, or cocaine or crack cocaine at least once per month, 99.1%, 56.8%, 42.2%, and 55.7% reported testing these drugs, respectively. Test strip use is supported by information from suppliers, regular transportation, diverse distribution locations, recommendations from harm reduction staff, and having a safe or private place to use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found that individuals who use fentanyl test strips are more often non-Hispanic white, use heroin, and seek drugs with fentanyl relative to individuals without test strip use. Findings confirm high fentanyl penetration in the Wisconsin drug supply. Low rates of stimulant testing suggest inadequate awareness of fentanyl penetration. Findings support outreach to key populations, increased diversity of distributing locations, efforts to correct misperceptions about drug wasting, emphasis on pre-consumption testing, and the importance of adjunct behaviors to prevent overdose given high rates of intentional fentanyl use.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00720-7","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T05:22:00Z","timestamp":1671081720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin"],"prefix":"10.1186","volume":"19","author":[{"given":"Alyssa Shell","family":"Tilhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen","family":"Birstler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Baltes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Salisbury-Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Malicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"50\u201351","key":"720_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","volume":"65","author":"R Rudd","year":"2016","unstructured":"Rudd R, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65(50\u201351):1445\u201352.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"720_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019. Morb Mortal Wkly Rep. 2021;70(6):202.","journal-title":"Morb Mortal Wkly Rep"},{"key":"720_CR3","unstructured":"National Institute on Drug Abuse. Overdose death rates. [cited 2020 Mar 27]. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates."},{"key":"720_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"720_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137\u201345.","journal-title":"Ann Intern Med"},{"key":"720_CR6","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"issue":"2","key":"720_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2105\/AJPH.2021.306577","volume":"112","author":"J Saini","year":"2022","unstructured":"Saini J, Johnson B, Qato DM. Self-reported treatment need and barriers to care for adults with opioid use disorder: the US national survey on drug use and health, 2015 to 2019. Am J Public Health. 2022;112(2):284\u201395.","journal-title":"Am J Public Health"},{"key":"720_CR8","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2018 national survey on drug use and health. 2019 [cited 2022 Aug 29]; Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHNationalFindingsReport2018\/NSDUHNationalFindingsReport2018.pdf."},{"key":"720_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","volume":"63","author":"NC Peiper","year":"2019","unstructured":"Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122\u20138.","journal-title":"Int J Drug Policy"},{"key":"720_CR10","unstructured":"Sherman SG, Park JN, Glick J, McKenzie M, Morales K, Christensen T, et al. FORECAST study summary report. Johns Hopkins Bloomberg School of Public Health; 2018. Available from: https:\/\/americanhealth.jhu.edu\/sites\/default\/files\/inline-files\/Fentanyl_Executive_Summary_032018.pdf."},{"issue":"1","key":"720_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BD. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):1\u201311.","journal-title":"Harm Reduct J"},{"key":"720_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","volume":"61","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52\u20138.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"720_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0213-2","volume":"15","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):1\u20139.","journal-title":"Harm Reduct J"},{"key":"720_CR14","unstructured":"Marshall K. Fentanyl test strip pilot. Harm reduction coalition; 2018 Feb [cited 2020 Jan 28]. Available from: https:\/\/harmreduction.org\/issue-area\/overdose-prevention-issue-area\/fentanyl-test-strip-pilot\/."},{"issue":"1","key":"720_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0252-8","volume":"15","author":"M Karamouzian","year":"2018","unstructured":"Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15(1):1\u20138.","journal-title":"Harm Reduct J"},{"key":"720_CR16","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.drugpo.2020.102900","volume":"84","author":"NP Weicker","year":"2020","unstructured":"Weicker NP, Owczarzak J, Urquhart G, Park JN, Rouhani S, Ling R, et al. Agency in the fentanyl era: exploring the utility of fentanyl test strips in an opaque drug market. Int J Drug Policy. 2020;84:102900.","journal-title":"Int J Drug Policy"},{"key":"720_CR17","doi-asserted-by":"publisher","first-page":"109425","DOI":"10.1016\/j.drugalcdep.2022.109425","volume":"234","author":"CS Davis","year":"2022","unstructured":"Davis CS, Lieberman AJ, O\u2019Kelley-Bangsbergn M. Legality of drug checking equipment in the United States: a systematic legal analysis. Drug Alcohol Depend. 2022;234:109425.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"720_CR18","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.2105\/AJPH.2019.305268","volume":"109","author":"CS Davis","year":"2019","unstructured":"Davis CS, Carr DH, Samuels EA. Paraphernalia laws, criminalizing possession and distribution of items used to consume illicit drugs, and injection-related harm. Am J Public Health. 2019;109(11):1564\u20137.","journal-title":"Am J Public Health"},{"issue":"14","key":"720_CR19","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jama.2014.2147","volume":"311","author":"Y Olsen","year":"2014","unstructured":"Olsen Y, Sharfstein JM. Confronting the stigma of opioid use disorder\u2014and its treatment. JAMA. 2014;311(14):1393\u20134.","journal-title":"JAMA"},{"issue":"1","key":"720_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00373-4","volume":"17","author":"B Wallace","year":"2020","unstructured":"Wallace B, van Roode T, Pagan F, Phillips P, Wagner H, Calder S, et al. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduct J. 2020;17(1):1\u201314.","journal-title":"Harm Reduct J"},{"key":"720_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","volume":"61","author":"MA Priester","year":"2016","unstructured":"Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat. 2016;61:47\u201359.","journal-title":"J Subst Abuse Treat"},{"issue":"sup1","key":"720_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/09540120600839397","volume":"18","author":"R Whetten","year":"2006","unstructured":"Whetten R, Whetten K, Pence BW, Reif S, Conover C, Bouis S. Does distance affect utilization of substance abuse and mental health services in the presence of transportation services? AIDS Care. 2006;18(sup1):27\u201334.","journal-title":"AIDS Care"},{"issue":"2","key":"720_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0740-5472(01)00185-4","volume":"21","author":"PD Friedmann","year":"2001","unstructured":"Friedmann PD, Lemon SC, Stein MD. Transportation and retention in outpatient drug abuse treatment programs. J Subst Abuse Treat. 2001;21(2):97\u2013103.","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"720_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3109\/10826084.2014.891618","volume":"49","author":"M Phillips","year":"2014","unstructured":"Phillips M, DeBeck K, Desjarlais T, Morrison T, Feng C, Kerr T, et al. Inability to access addiction treatment among street-involved youth in a Canadian setting. Subst Use Misuse. 2014;49(10):1233\u201340.","journal-title":"Subst Use Misuse"},{"key":"720_CR25","doi-asserted-by":"publisher","first-page":"108790","DOI":"10.1016\/j.jsat.2022.108790","volume":"140","author":"MK Reed","year":"2022","unstructured":"Reed MK, Salcedo VJ, Guth A, Rising KL. \u201cIf I had them, I would use them every time\u201d: perspectives on fentanyl test strip use from people who use drugs. J Subst Abuse Treat. 2022;140:108790.","journal-title":"J Subst Abuse Treat"},{"key":"720_CR26","doi-asserted-by":"publisher","first-page":"103643","DOI":"10.1016\/j.drugpo.2022.103643","volume":"103","author":"MK Reed","year":"2022","unstructured":"Reed MK, Guth A, Salcedo VJ, Hom JK, Rising KL. \u201cYou can\u2019t go wrong being safe\u201d: motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs. Int J Drug Policy. 2022;103:103643.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"720_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/aje\/kwab233","volume":"191","author":"N Dasgupta","year":"2022","unstructured":"Dasgupta N, Figgatt MC. Invited commentary: drug checking for novel insights into the unregulated drug supply. Am J Epidemiol. 2022;191(2):248\u201352.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"720_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res"},{"key":"720_CR29","doi-asserted-by":"crossref","unstructured":"Weller S, Romney A. Defining a domain and free listing. In: Systematic Data collection (Qualitative research methods; vol. 10). Newbury Park: Sage Publications Inc; 1988.","DOI":"10.4135\/9781412986069.n2"},{"issue":"2","key":"720_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"720_CR31","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"720_CR32","unstructured":"Wisconsin Network for Research Support. CARDS [Internet]. [cited 2022 Mar 4]. Available from: https:\/\/winrs.nursing.wisc.edu\/services\/cards\/."},{"key":"720_CR33","unstructured":"2010 Rural-Urban Commuting Area (RUCA) Codes [Internet]. 2020 Aug [cited 2022 Feb 24]. Available from: https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/documentation\/."},{"issue":"7","key":"720_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/cap.2019.0013","volume":"29","author":"RM Lyons","year":"2019","unstructured":"Lyons RM, Yule AM, Schiff D, Bagley SM, Wilens TE. Risk factors for drug overdose in young people: a systematic review of the literature. J Child Adolesc Psychopharmacol. 2019;29(7):487\u201397.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"720_CR35","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1046\/j.1360-0443.2003.00376.x","volume":"98","author":"PO Coffin","year":"2003","unstructured":"Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990\u201398. Addiction. 2003;98(6):739\u201347.","journal-title":"Addiction"},{"issue":"11","key":"720_CR36","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","volume":"105","author":"SS Martins","year":"2015","unstructured":"Martins SS, Sampson L, Cerd\u00e1 M, Galea S. Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. Am J Public Health. 2015;105(11):e29-49.","journal-title":"Am J Public Health"},{"key":"720_CR37","unstructured":"Wisconsin Department of Health Services. Dose of reality: opioid deaths by county dashboard. 2022 Feb [cited 2022 Aug 12]. Available from: https:\/\/www.dhs.wisconsin.gov\/opioids\/deaths-county.htm."},{"key":"720_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11524-022-00663-1","volume":"99","author":"PO Coffin","year":"2022","unstructured":"Coffin PO, McMahan VM, Murphy C. Evidence of pre-mortem opioid use among fentanyl overdose decedents in a safety net healthcare system. J Urban Health. 2022;99:1\u20138.","journal-title":"J Urban Health"},{"issue":"8","key":"720_CR39","doi-asserted-by":"publisher","first-page":"e2226544","DOI":"10.1001\/jamanetworkopen.2022.26544","volume":"5","author":"PT Korthuis","year":"2022","unstructured":"Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, et al. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Netw Open. 2022;5(8):e2226544\u2013e2226544.","journal-title":"JAMA Netw Open"},{"issue":"34","key":"720_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","volume":"68","author":"RM Gladden","year":"2019","unstructured":"Gladden RM, O\u2019Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine\u201425 states, July\u2013December 2017 to January\u2013June 2018. Morb Mortal Wkly Rep. 2019;68(34):737.","journal-title":"Morb Mortal Wkly Rep"},{"key":"720_CR41","doi-asserted-by":"publisher","first-page":"108976","DOI":"10.1016\/j.drugalcdep.2021.108976","volume":"228","author":"L Karch","year":"2021","unstructured":"Karch L, Tobias S, Schmidt C, Doe-Simkins M, Carter N, Salisbury-Afshar E, et al. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA. Drug Alcohol Depend. 2021;228:108976.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"720_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-022-00590-z","volume":"19","author":"JJ Carroll","year":"2022","unstructured":"Carroll JJ, Mackin S, Schmidt C, McKenzie M, Green TC. The Bronze age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19. Harm Reduct J. 2022;19(1):1\u201313.","journal-title":"Harm Reduct J"},{"issue":"6","key":"720_CR43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11524-020-00439-5","volume":"97","author":"L Dayton","year":"2020","unstructured":"Dayton L, Tobin K, Falade-Nwulia O, Davey-Rothwell M, Al-Tayyib A, Saleem H, et al. Racial disparities in overdose prevention among people who inject drugs. J Urban Health. 2020;97(6):823\u201330.","journal-title":"J Urban Health"},{"issue":"8","key":"720_CR44","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/add.12961","volume":"110","author":"C Rowe","year":"2015","unstructured":"Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015;110(8):1301\u201310.","journal-title":"Addiction"},{"issue":"S2","key":"720_CR45","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.2105\/AJPH.2022.306767","volume":"112","author":"AM Lopez","year":"2022","unstructured":"Lopez AM, Thomann M, Dhatt Z, Ferrera J, Al-Nassir M, Ambrose M, et al. Understanding racial inequities in the implementation of harm reduction initiatives. Am J Public Health. 2022;112(S2):S173\u201381.","journal-title":"Am J Public Health"},{"issue":"3","key":"720_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/add.15233","volume":"116","author":"D Furr-Holden","year":"2021","unstructured":"Furr-Holden D, Milam AJ, Wang L, Sadler R. African Americans now outpace whites in opioid-involved overdose deaths: a comparison of temporal trends from 1999 to 2018. Addiction. 2021;116(3):677\u201383.","journal-title":"Addiction"},{"issue":"43","key":"720_CR47","doi-asserted-by":"publisher","first-page":"967","DOI":"10.15585\/mmwr.mm6843a3","volume":"68","author":"KM Lippold","year":"2019","unstructured":"Lippold KM, Jones CM, Olsen EO, Giroir BP. Racial\/ethnic and age group differences in opioid and synthetic opioid\u2013involved overdose deaths among adults aged\u2265 18 years in metropolitan areas\u2014United States, 2015\u20132017. Morb Mortal Wkly Rep. 2019;68(43):967.","journal-title":"Morb Mortal Wkly Rep"},{"key":"720_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugpo.2019.01.017","volume":"66","author":"B Wallace","year":"2019","unstructured":"Wallace B, Pagan F, Pauly BB. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. Int J Drug Policy. 2019;66:64\u201372.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"720_CR49","doi-asserted-by":"publisher","first-page":"e0229208","DOI":"10.1371\/journal.pone.0229208","volume":"15","author":"B Pauly","year":"2020","unstructured":"Pauly B, Wallace B, Pagan F, Phillips J, Wilson M, Hobbs H, et al. Impact of overdose prevention sites during a public health emergency in Victoria, Canada. PLoS ONE. 2020;15(5):e0229208.","journal-title":"PLoS ONE"},{"key":"720_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: What has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368.","journal-title":"Drug Alcohol Depend"},{"key":"720_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","volume":"169","author":"LT Wu","year":"2016","unstructured":"Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117\u201327.","journal-title":"Drug Alcohol Depend"},{"key":"720_CR52","doi-asserted-by":"publisher","first-page":"102661","DOI":"10.1016\/j.drugpo.2020.102661","volume":"77","author":"TC Green","year":"2020","unstructured":"Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int J Drug Policy. 2020;77:102661.","journal-title":"Int J Drug Policy"},{"key":"720_CR53","doi-asserted-by":"publisher","first-page":"103065","DOI":"10.1016\/j.drugpo.2020.103065","volume":"90","author":"MSS Bergh","year":"2021","unstructured":"Bergh MSS, \u00d8iestad \u00c5ML, Baumann MH, Bogen IL. Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs. Int J Drug Policy. 2021;90:103065.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00720-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T06:07:21Z","timestamp":1671084441000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00720-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00720-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"6 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board at the University of Wisconsin School of Medicine and Public Health. All respondents provided informed consent prior to participation in both study phases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}